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Introduction: Hashimoto’s encephalopathy is a relatively rare condition associated with an elevated concentration
of circulating serum anti-thyroid antibodies, and is usually responsive to steroid therapy. However, hypothyroidism
is a rare cause of pseudo-obstruction so here we present a case report of Hashimoto’s encephalopathy with gut
pseudo-obstruction in an undiagnosed hypothyroid patient.
Case presentation: A diagnosis of unknown aetiology of encephalopathy with gut dysmotility in an undiagnosed
profound hypothyroidism case associated with cognitive decline and behavioural disorder was made in a 60-year-old
Indian man. The associated clinical and laboratory features led to the final diagnosis of overt hypothyroidism with
Hashimoto’s encephalopathy with gut pseudo-obstruction.
Conclusions: Hashimoto’s encephalopathy is a rare disorder presenting with acute or sub acute encephalopathy of
unknown aetiology so there are considerable chances of misdiagnosing it. The unusualness of this case is that since
hypothyroidism is a rare cause of intestinal pseudo-obstruction, and presented concomitant with Hashimoto’s
encephalopathy, that itself is a rare entity. Intestinal pseudo-obstruction is a potentially serious complication that must
be recognized and treated promptly with adequate thyroid hormone therapy.
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Hypothyroidism is a disorder caused by hypofunction of
the thyroid gland. Iodine deficiency is the most common
cause of hypothyroidism worldwide; however, in areas of
iodine sufficiency Hashimoto’s thyroiditis and iatrogenic
causes are most common. Because of its autoimmune
nature there is a gradual decline in thyroid function with
presentation of a wide range of disease symptoms. Some
patients may have minor symptoms, which is called
subclinical hypothyroidism, whereas others have a fall in
unbound T4 levels and a steep rise in thyroid-stimulating
hormone (TSH)>10μIU/L, which is referred to as clinical
or overt hypothyroidism [1].
Lord Brain in 1966 described Hashimoto’s encephalopathy
(HE) in a patient with Hashimoto’s thyroiditis as charac-
terized by cloudiness of consciousness, tremors, cognitive* Correspondence: sherairfan@gmail.com
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unless otherwise stated.loss and stroke-like episodes [2]. Since then HE has gained
importance in differential diagnosis of encephalopathy of
unknown origin. Shaw [3] in 1991 coined the term HE by
describing the constellation of symptoms such as seizure,
disorientation, frequent episodes of alternating hemiparesis,
high protein levels in cerebrospinal fluid (CSF) and
electrocardiogram (ECG) abnormalities. However, these
patients also had hypothyroidism and positive anti-thyroid
antibodies. Because of the severe neurological complexities
the term HE is widely used while some other terms such
as myxoedema madness [4], encephalopathy associated
with autoimmune thyroid disease [5] or steroid responsive
encephalopathy associated with autoimmune thyroiditis [6]
have been discarded.
HE is a relatively rare condition; therefore there are
considerable chances of misdiagnosing it. HE is generally
considered to be an autoimmune encephalopathy; however
the pathogenesis is still not clear. Antithyroid peroxidase
(anti-TPO) antibodies are found in almost all cases of HE
[7] but can also be present in the general population withtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ated that there exists no direct causal relationship between
anti-TPO antibodies and HE [9]. Hypothyroidism has
frequently been associated with various gastrointestinal
manifestations including constipation, bloating, flatulence,
atrophic gastritis, ileus, atony and dilatation of oesophagus,
stomach, gallbladder, small intestines and colon. Character-
istic intestinal hypomotility in severe hypothyroidism
may progress to intestinal pseudo-obstruction, paralytic
ileus and megacolon [10]. Hypothyroidism is a rare cause
of intestinal obstruction that can be reversed with thyroid
hormone therapy.
Here we present a case report of HE with gut pseudo-
obstruction. To the best of our knowledge this concomitant
entity has not been reported to date.
Case presentation
A 60-year-old non-alcoholic, non-diabetic, normotensive
Indian man of the state of Uttar Pradesh, working in
printing press was brought to our emergency department
with history of altered sensorium and abdomen distension
of two days’ duration. There was history of slow men-
tation, cognitive decline characterized by inattention,
and difficulty in finding words which prevented him
from performing routine activities for the last three
months. He also had behavioural disorder in the form of
agitation, hallucinations and delusions of persecution.
He had constipated bowel habits. There was no his-
tory of any drug intake.
On examination he was drowsy. He had a hoarse voice,
dry skin, puffy face, madarosis and cold extremities. He
had a distended abdomen (Figure 1) with absent bowel
sounds. He had sluggish deep tendon reflexes all over.
Chest and cardiovascular examinations were normal.
Laboratory investigations revealed macrocytic (mean
corpuscular volume: 100) hypochromic anaemia (haemo-
globin: 9.1g/dL) with leucopenia (total leukocyte count:Figure 1 Figure showing distended abdomen.3900 per mm). His blood sugar, liver function test, kidney
function test, arterial blood gas and electrolytes were
within normal limits. His urine examination was normal.
He had a sterile septic profile. A chest X-ray and ECG
were normal. Abdominal ultrasonography revealed
gaseous distention with dilated bowel loops. An X-ray
of his abdomen showed features of obstruction with
dilated gut loops and air-fluid levels (Figures 2 and 3).
Axial contrast-enhanced computed tomography image of
his abdomen showed dilated bowel loops (Figure 4).
A whole body computed tomography (CT) scan was incon-
clusive. Erythrocyte sedimentation rate, C-reactive protein,
antinuclear antibodies and human immunodeficiency virus
serology were normal. Physical examination of his thyroid
gland was unremarkable. A CT scan showed his thyroid
gland to be diffusely atrophic with decreased attenu-
ation. A thyroid profile revealed TSH of 76.52μIU/mL
(normal: 0.39 to 3.55μIU/mL) with free thyroxine (FT4)
of 0.1ng/dL (normal: 0.75 to 1.54ng/dL) and free
triiodothyronine (FT3) of 0.42pg/mL (normal: 2.0 to
4.9pg/mL). His serum anti-TPO antibody level was 581
units/mL (normal: <60 units/mL). Magnetic resonance
imaging (MRI) of his brain showed mild diffuse cerebral
atrophy; fluid-attenuated inversion recovery (FLAIR)
sequence showing prominent bilateral cortical sulci
and Sylvian fissures with bilateral periventricular ooze
(Figure 5), T2/FLAIR hyperintensities in bilateral peri-
ventricular and sub-cortical white matter suggestive
of chronic ischemic changes were found (Figure 6).
An electroencephalogram was normal. CSF examination
showed reactivity for anti-TPO antibodies with elevated
proteins and normal sugar level.
Special investigations were carried out, such as glucose
hydrogen breath test was normal, serum cobalamin levelFigure 2 Supine abdominal plain film showing air-filled
distended gut loops.
Figure 3 Upright abdominal plain film showing air-fluid level in
dilated gut loops.
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was 2.19μg/dL (normal: <25μg/dL) and gut manometry
showed change in the frequency of the slow wave
oscillations of smooth muscle electric potential features
suggestive of intestinal dysmotility.
Final diagnosis of overt hypothyroidism with HE
with pseudo-obstruction was made. He received hydrocor-
tisone 200mg/day IV for a period of seven days which re-
sulted in a significant improvement in his clinical condition
after the third day of treatment. He became alert, oriented
with time, place and person, and responded well to
verbal commands. His mini-mental score was 14/30;Figure 4 Axial contrast-enhanced computed tomography
image shows dilated bowel loops.it was not possible to compute this score earlier
because he presented with altered sensorium. The
treatment was maintained by tapering the dose of
prednisone over a period of six weeks. He received
levothyroxine 100μg/day orally from the second day of his
diagnosis. His pseudo-obstruction was managed conserva-
tively with Ryles tube suctioning, proctoclysis enema,
metoclopramide and erythromycin. His bowel sounds
resumed and he passed flatus on the second day of his
admission. However, his abdominal distension regressed
slowly over a period of one month. One month after dis-
charge, he had remarkable improvement in all parameters
including memory and cognition that made it possible for
him to return to routine work. His CSF was re-examined
after six weeks of steroid therapy and it was normal.
His mini-mental score improved to 28/30 at six weeks
of his follow up. Currently he is on levothyroxine
75μg/day with latest thyroid profile of: TSH of 4.3μIU/mL,
FT4 of 1.2ng/dL, FT3 of 3.45pg/mL and anti-TPO
antibodies level of 85 units/mL.
Discussion
Clinical features of hypothyroidism usually have an insidi-
ous onset and affect a wide range of organ systems before
one can make perfect diagnosis of overt hypothyroidism.
In our case our patient was not aware of symptoms until
he presented with neuropsychiatric syndrome and features
of gut dysmotility.
HE is a rare neuropsychiatric syndrome, more common
in women, associated with serologic evidence of antithy-
roid antibodies,when other causes of encephalopathy are
excluded [11]. Our patient presented with encephalopathy
with gut obstruction that could have indicated infectious,
inflammatory, neoplastic, toxic and metabolic aetiologies.
The authors ruled out all possibility of close differential
diagnoses such as chronic lead toxicity as he had occupa-
tional exposure to lead, megaloblastic anaemia, gut neopla-
sia with overwhelming sepsis and brain metastasis. The
MRI of the brain of our patient showed mild diffuse cere-
bral atrophy, prominent bilateral cortical sulci and Sylvian
fissures with bilateral periventricular ooze associated with
white matter ischemic lesions. The diverse MRI features of
HE can vary from normal appearance, ischemic lesions,
demyelination and vasogenic oedema to atrophy [12]. Our
patient’s elevated anti-TPO antibodies in his serum and
CSF and his response to steroid therapy seemed appropri-
ate to establish a certain diagnosis.
The responsiveness of steroid therapy was the corner-
stone for diagnosing HE. It is obvious that he responded
to hydrocortisone, although levothyroxine was started
from day two. This can be justified from the fact that
levothyroxine has a half-life of approximately seven days;
it will take at least six to eight weeks for a patient to
become euthyroid, before one could recognize effectiveness
Figure 5 Fluid-attenuated inversion recovery sequence showing prominent bilateral cortical sulci and Sylvian fissures with bilateral
periventricular ooze.
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responded to steroids dramatically rather than to thyroid
therapy. However, his abdominal distension regressed slowly
over a period of one month, once he attained euthyroid
state, which made us conclusive that pseudo-obstruction of
gut was consequence of profound hypothyroidism that
responded to thyroid replacement.
Hypothyroid patients often complain of constipation
and their gastric emptying time may be significantly
delayed [13]. Myxedema ileus uncommonly complicates
the hypothyroid state and is a rare cause of intestinal
pseudo-obstruction that can return to normal after the thy-
roid disorder is corrected [14]. Our patient had constipa-
tion and small intestinal transit was significantly slowed as
revealed by gut manometry. Profound hypothyroidism can
cause intestinal dysmotility, results in paralytic ileus andFigure 6 T2 magnetic resonance imaging image showing
hyperintensities in periventricular areas.intestinal pseudo-obstruction. These features respond to the
thyroid hormone replacement therapy gradually over time.
It was further observed that he had a hoarse voice that
reflected fluid accumulation in his vocal cords and tongue.
Moreover, typical features of hypothyroidism such as dry
coarse skin, puffy face with oedematous eyelids and non-
pitting pretibial oedema were present in our patient.
Conclusions
HE is a rare disorder with varying clinical manifestations
that should be considered in any patient presenting
with acute or subacute encephalopathy of unknown
aetiology. Hypothyroidism is a rare cause of intestinal
pseudo-obstruction which is a potentially serious complica-
tion that must be recognized and treated promptly.
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